Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Fexofenadine Hydrochloride Tablets

Approval Number

国药准字HJ20210011

CompanyOPELLA HEALTHCARE FRANCE SAS

Registration Date

February 10, 2021

Drug Information

Generic Name

盐酸非索非那定片

Dosage Form

片剂

Strength

120mg

Drug Type

化学药品

Registration Date

February 10, 2021

Expiry Date

February 9, 2026

Company Information

Applicant Company

Company NameOPELLA HEALTHCARE FRANCE SAS

Company Address

157 avenue Charles de Gaulle 92200 Neuilly Sur Seine, France

Manufacturing Company

Company NameSANOFI WINTHROP INDUSTRIE

Company Address

30-36 AVENUE GUSTAVE EIFFEL, 37100 TOURS, FRANCE

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy